![Teva Pharmaceutical (TEVA) Presents At 38th Annual J.P. Morgan Healthcare Conference - Slideshow (NYSE:TEVA) | Seeking Alpha Teva Pharmaceutical (TEVA) Presents At 38th Annual J.P. Morgan Healthcare Conference - Slideshow (NYSE:TEVA) | Seeking Alpha](https://static2.seekingalpha.com/uploads/sa_presentations/360/50360/slides/10.jpg?1579019835)
Teva Pharmaceutical (TEVA) Presents At 38th Annual J.P. Morgan Healthcare Conference - Slideshow (NYSE:TEVA) | Seeking Alpha
![Teva UK в Twitter: „🏆 We were proud to walk away with three awards for @sudocrem and @Infacol at the 25th annual OTC Marketing Awards, held last week in London. Read more Teva UK в Twitter: „🏆 We were proud to walk away with three awards for @sudocrem and @Infacol at the 25th annual OTC Marketing Awards, held last week in London. Read more](https://pbs.twimg.com/media/ESwFnaZWAAA5t1Z.jpg)
Teva UK в Twitter: „🏆 We were proud to walk away with three awards for @sudocrem and @Infacol at the 25th annual OTC Marketing Awards, held last week in London. Read more
![Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler® (fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir® Digihaler® (fluticasone propionate) Inhalation Powder Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler® (fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir® Digihaler® (fluticasone propionate) Inhalation Powder](https://mms.businesswire.com/media/20200921005170/en/819864/4/Interactive_Media_Placeholder_webready.jpg)
Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler® (fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir® Digihaler® (fluticasone propionate) Inhalation Powder
![The Procter & Gamble Company and Teva Pharmaceutical Industries Announce Formation of New Consumer Health Care Partnership | Procter & Gamble News The Procter & Gamble Company and Teva Pharmaceutical Industries Announce Formation of New Consumer Health Care Partnership | Procter & Gamble News](https://s25.q4cdn.com/264117071/files/doc_multimedia/2011/11/World's-Leading-Seller-of-Medicines.jpg)
The Procter & Gamble Company and Teva Pharmaceutical Industries Announce Formation of New Consumer Health Care Partnership | Procter & Gamble News
![Teva Announces Launch of First-to-Market Generic Version of Narcan® (Naloxone Hydrochloride Nasal Spray), in the U.S. | Business Wire Teva Announces Launch of First-to-Market Generic Version of Narcan® (Naloxone Hydrochloride Nasal Spray), in the U.S. | Business Wire](https://mms.businesswire.com/media/20211222005564/en/739014/22/teva_RGB_JPEG.jpg)
Teva Announces Launch of First-to-Market Generic Version of Narcan® (Naloxone Hydrochloride Nasal Spray), in the U.S. | Business Wire
![ADDING MULTIMEDIA Teva Announces U.S. Approval of AJOVYTM (fremanezumab-vfrm) Injection, the First and Only Anti-CGRP Treatment with Both Quarterly and Monthly Dosing for the Preventive Treatment of Migraine in Adults | Business ADDING MULTIMEDIA Teva Announces U.S. Approval of AJOVYTM (fremanezumab-vfrm) Injection, the First and Only Anti-CGRP Treatment with Both Quarterly and Monthly Dosing for the Preventive Treatment of Migraine in Adults | Business](https://mms.businesswire.com/media/20180914005613/en/678526/5/AJOVY+Image.jpg)